Sharlene Gill

37PUBLICATIONS
163CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 27, 2026
Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26-27 September 2025: Advances in Colon and Rectal Cancer.

|May 31, 2026
Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

|May 26, 2026
Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinoma.

|Mar 07, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

Daniel J Renouf, James T Topham, Jonathan M Loree

|Nov 26, 2025
Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options.

Jacob C Easaw, Howard J Lim, Hatim Karachiwala

|Oct 20, 2025
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.

Jeanne Tie, Yuxuan Wang, Jonathan M Loree

Pageof 7

Frequent Collaborators

13 joint publications

Jonathan M Loree

9 joint publications

Mary A De Vera

6 joint publications

Ravi Ramjeesingh

5 joint publications

Daniel J Renouf